Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Vaezi

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Scientific Reports|December 4, 2025
Prophylactic infusion of donor derived CMV specific T cells for the prevention of CMV reactivation following allogeneic HSCTMaryam Barkhordar, Maryam Samareh Salavatipour, Shirin Tavakoli, et al.
Reviews in Medical Virology|June 15, 2024
Efficacy and safety of adoptive T-cell therapy in treating cytomegalovirus infections post-haematopoietic stem cell transplantation: A systematic review and meta-analysisMohammad Reza Taherian, Pouya Azarbar, Maryam Barkhordar, et al.
Leukemia Research|February 7, 2018
Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRAArdeshir Ghavamzadeh, Mahdi Jalili, Sharbanoo Rostami, et al.
Advanced Pharmaceutical Bulletin|July 10, 2025
Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric AdenocarcinomaMaryam Samareh-Salavatipour, Shirin Tavakoli, Maryam Barkhordar, et al.
Advanced Pharmaceutical Bulletin|April 7, 2025
Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular CarcinomaShirin Tavakoli, Maryam Samareh-Salavati, Shahrokh Abdolahi, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|June 5, 2019
Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective studyHasan Jalaeikhoo, Mohammad Zokaasadi, Ahmad Khajeh-Mehrizi, et al.
Middle East Journal of Digestive Diseases|September 7, 2018
Sixteen Years of Experience with the Treatment of Advanced Colorectal Cancer in Iran; A Report from Three InstitutionsHasan Jalaeikhoo, Ahmad Khajeh-Mehrizi, Mohammad Zokaasadi, et al.
Frontiers in Oncology|March 8, 2024
Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center studyMojtaba Azari, Maryam Barkhordar, Tanaz Bahri, et al.
Frontiers in Oncology|May 3, 2024
Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center studyMojtaba Azari, Maryam Barkhordar, Tanaz Bahri, et al.
Blood Research|April 9, 2026
Autologous bone marrow transplantation in non-hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental studySahar Tavakoli Shiraji, Mohammad Biglari, Soroush Rad, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Scientific Reports|December 4, 2025
Prophylactic infusion of donor derived CMV specific T cells for the prevention of CMV reactivation following allogeneic HSCTMaryam Barkhordar, Maryam Samareh Salavatipour, Shirin Tavakoli, et al.
Reviews in Medical Virology|June 15, 2024
Efficacy and safety of adoptive T-cell therapy in treating cytomegalovirus infections post-haematopoietic stem cell transplantation: A systematic review and meta-analysisMohammad Reza Taherian, Pouya Azarbar, Maryam Barkhordar, et al.
Leukemia Research|February 7, 2018
Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRAArdeshir Ghavamzadeh, Mahdi Jalili, Sharbanoo Rostami, et al.
Advanced Pharmaceutical Bulletin|July 10, 2025
Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric AdenocarcinomaMaryam Samareh-Salavatipour, Shirin Tavakoli, Maryam Barkhordar, et al.
Advanced Pharmaceutical Bulletin|April 7, 2025
Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular CarcinomaShirin Tavakoli, Maryam Samareh-Salavati, Shahrokh Abdolahi, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|June 5, 2019
Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective studyHasan Jalaeikhoo, Mohammad Zokaasadi, Ahmad Khajeh-Mehrizi, et al.
Middle East Journal of Digestive Diseases|September 7, 2018
Sixteen Years of Experience with the Treatment of Advanced Colorectal Cancer in Iran; A Report from Three InstitutionsHasan Jalaeikhoo, Ahmad Khajeh-Mehrizi, Mohammad Zokaasadi, et al.
Frontiers in Oncology|March 8, 2024
Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center studyMojtaba Azari, Maryam Barkhordar, Tanaz Bahri, et al.
Frontiers in Oncology|May 3, 2024
Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center studyMojtaba Azari, Maryam Barkhordar, Tanaz Bahri, et al.
Blood Research|April 9, 2026
Autologous bone marrow transplantation in non-hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental studySahar Tavakoli Shiraji, Mohammad Biglari, Soroush Rad, et al.
Pageof 12